Overview IQVIA provides scientific services spanning clinical trials, real world evidence, preference research, and consulting in all areas of the medical product lifecycle. The Patient Centered Solutions (PCS) team leads the industry in generating data to ensure that the patient voice is incorporated into the development and commercialization of medication and other drug/non-drug interventions. We focus on understanding and meeting the needs of our clients – mostly life science/pharmaceutical companies – through the application of broad consulting expertise and technical scientific knowledge to design scientifically rigorous research. This research is broad and includes qualitative (e.g., interviews, focus groups), quantitative (e.g., clinical outcome assessments (COAs)/patient-reported outcomes (PROS), preference research) and passive (e.g., digital health technology tools) approaches to understand patient, caregiver and healthcare professional experiences and expectations of disease and treatment.
IQVIA PCS has grown to be the largest Patient Experience Data (PED) expert team in the industry with over 400 dedicated staff, and offerings spanning strategic consulting, scientific services through to COA licensing and technology. The business has matured and continues to show strong growth in North America and Europe. Customers in the Asia Pacific and Japan regions have been served opportunistically or when we work with their regional headquarters in US and Europe. The Associate Principal Strategic Program expansion (APAC & Japan) will work with senior leadership in PCS, Asia and Japan to develop and execute the expansion of PCS into these regions. Reporting to, and taking strategic guidance and direction from the VP Global SSR (strategic scientific research), this role will support the development and coordination of the overall business plan including: taking and adapting as needed PCS offerings to market in Asia; defining the delivery model; and informing the planning for headcount and capability building. This role will directly inform and impact the strategy and its execution for PCS growth in APAC and Japan, and offers a unique opportunity to engage with IQVIA senior leaders across the globe whilst developing business skills and learning about the field of PED and Clinical Outcome Assessments (COAs).
Key responsibilities are: Support the development of and responsible for maintaining the overall 3-year project plan for PCS APAC and Japan expansion, with details for the first 18-24 months.
Develop customer collateral and training materials for Go to Market teams and facilitate the delivery of training alongside PCS subject matter experts.
Design and lead workstreams to inform the expansion strategy and tactics, for example, landscape and market analysis to identify customer needs, customer targeting, and marketing and promotion planning, working in close collaboration with resources in APAC and Japan.
Design and lead selected build workstreams which could include, for example, capability mapping the existing APAC and Japan organisations for conducting PCS SSR work, and designing the future delivery model.
Adapt GBU and US/EMEA RBU processes for triaging client enquiries and RFPs from APAC and Japan to receive PCS expert support and leadership; and support local implementation of these processes.
Assist in creating project communications and a cadence of status reports for senior leaders and executives in global RWS, APAC and Japan. Includes developing slide decks, written communications, soliciting input from other workstream leads, and establishing a regular reporting cadence.
Contribute to cross-business line initiatives that relate to APAC and Japan, for example, to understand data privacy regulations in key markets.
Develop a broad knowledge of PED and how it addresses client needs for evidence generation and dissemination, regulatory and market access strategy.
Line manage 3-4 junior consultants in the PCS team who provide delivery capacity for SSR projects in APAC and Japan.
As the business opportunities in the regions develop, lead or contribute to proposals; act as Engagement Lead to deliver selected projects.
About You Candidates interested in this position will have:
8-10 years experience in pharmaceutical and/or healthcare consulting within a Professional Services business with evidence of career progression.
Well-developed written and verbal communication skills including presentations, business and report writing.
An entrepreneurial nature and interest in developing new client offerings and solutions.
Previous experience within IQVIA of working with Real World or RDS sales teams or other roles with business development responsibility.
Knowledge of clinical development processes and real world evidence types is essential. Knowledge of healthcare regulatory processes and international payer systems is desirable.
Demonstrable analytical, interpretative, and problem-solving skills.
Excellent interpersonal skills and ability to work effectively with others.
An ability to work in a fast-paced environment with demonstrated ability to effectively manage multiple tasks.
An ability to establish and maintain effective working relationships in multi-disciplinary and international teams.
Flexibility to work across multiple time zones.
Previous exposure to COA/PRO and patient preference methods are desirable.
In addition to the skills and experience above the Associate Principal should have: Degree qualifications (ideally Masters level) in a life science discipline.
Fluency in English (spoken and written).
Willingness and ability to travel from time to time.
Right to live and work in the recruiting country.
PHYSICAL REQUIREMENTS Extensive use of telephone communication requiring accurate perception of speech.
Extensive use of keyboard requiring repetitive motion of fingers.
Regular sitting for extended periods of time.
(Travel as required.)
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
#J-18808-Ljbffr